Tatva Chintan Pharma Chem's Q3 FY 2025-26 Quarterly Results
- 17h ago
Result Summary
- Tatva Chintan Pharma Chem Ltd reported a 6.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 54.8%.
- Its expenses for the quarter were up by 4.1% QoQ and 33.9% YoY.
- The net profit increased 52.8% QoQ and increased 10728.6% YoY.
- The earnings per share (EPS) of Tatva Chintan Pharma Chem Ltd stood at 6.49 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 133.07 | 124.52 | 85.94 | 6.9% | 54.8% |
Total Expenses | 115.41 | 110.86 | 86.18 | 4.1% | 33.9% |
Profit Before Tax | 17.66 | 13.66 | -0.24 | 29.3% | -7458.3% |
Tax | 2.49 | 3.75 | -0.37 | -33.6% | -773.0% |
Profit After Tax | 15.16 | 9.92 | 0.14 | 52.8% | 10728.6% |
Earnings Per Share | 6.49 | 4.24 | 0.06 | 53.1% | 10716.7% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Tatva Chintan Pharma Chem Ltd is a company engaged in the chemical industry with a focus on the production and supply of specialty chemicals. The company's product portfolio typically includes phase transfer catalysts, structure-directing agents, electrolyte salts for supercapacitor batteries, and pharmaceutical and agrochemical intermediates. These products are utilized across various industries, including pharmaceuticals, agrochemicals, and electronics, highlighting the company's diverse market presence. Any recent major developments specific to the company's operations, such as expansions, new product launches, or strategic partnerships, are not provided in the given data.
Revenue
In the third quarter of the fiscal year 2026 (Q3FY26), Tatva Chintan Pharma Chem Ltd reported a total income of ₹133.07 crores. This reflects a quarter-over-quarter (QoQ) increase of 6.9% compared to the previous quarter (Q2FY26), where the income was ₹124.52 crores. Furthermore, a significant year-over-year (YoY) increase of 54.8% is observed when compared to the same quarter of the previous fiscal year (Q3FY25), which registered a total income of ₹85.94 crores. These figures indicate a strong upward trajectory in revenue generation over the analyzed periods.
Profitability
The company's profitability has shown substantial improvement in Q3FY26. The profit before tax (PBT) for this quarter stands at ₹17.66 crores, marking a 29.3% increase QoQ from ₹13.66 crores in Q2FY26. When compared to the same period in the previous year (Q3FY25), where the company experienced a slight loss with a PBT of -₹0.24 crores, this represents a remarkable turnaround. The profit after tax (PAT) also saw a significant increase to ₹15.16 crores in Q3FY26, up by 52.8% from ₹9.92 crores in Q2FY26, and an extraordinary YoY growth from ₹0.14 crores in Q3FY25. This improvement in profitability is further reflected in the earnings per share (EPS), which increased to ₹6.49 in Q3FY26 from ₹4.24 in the previous quarter and just ₹0.06 a year earlier.
Operating Metrics
The total expenses for the company in Q3FY26 were ₹115.41 crores, showing a 4.1% increase from ₹110.86 crores in Q2FY26. Compared to Q3FY25, when total expenses were ₹86.18 crores, there is a 33.9% increase YoY. The tax expense for Q3FY26 was ₹2.49 crores, which represents a decrease of 33.6% from ₹3.75 crores in Q2FY26. In comparison to Q3FY25, when the tax expense was -₹0.37 crores, there is a significant positive change. These figures illustrate changes in the company’s cost structure and the effective tax rate over the analyzed periods.